To include your compound in the COVID-19 Resource Center, submit it here.

FDA issues CRL to NDA for Vernalis' CCP-08

Vernalis plc (LSE:VER) said FDA issued a complete response letter to an NDA for

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE